Efficacy, Safety, Reactogenicity and Immunogenicity Study of the Lyophilised Formulation of Rotarix Vaccine in Healthy Japanese Infants.
Latest Information Update: 07 Sep 2023
At a glance
- Drugs RIX 4414 (Primary)
- Indications Gastroenteritis; Rotavirus infections
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 15 Feb 2020 Results of pooled analysis from nine studies including this study published in the Journal of Infectious Diseases.
- 01 Jun 2011 Final results published in Vaccine.
- 16 Nov 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.